Developer docs
API playgroundTry for free, no card

Search company profiles

Korean Investment Partners

Full company profile

uuid000byvt

Namestring
Korean Investment Partners
Legal namestring
Korea Investment Partners Co., Ltd.
Company typeenum
Private
Founded yearint
1986
Descriptiontext

Korea Investment Partners (KIP) is a Seoul-headquartered venture capital and private equity firm incorporated in 1986, operating as the dedicated investment arm of Korea Investment Holdings, one of Korea's largest financial conglomerates. The firm invests across five sector verticals — Biotech & Healthcare, Interactive Contents & Media, Consumer Internet & Fintech, ICT & Digitalization, and Semiconductor & Industrial — covering portfolio companies from early-stage ventures through growth-stage businesses.

KIP operates a fund-oriented platform managing at least four distinct vehicles: KIP Fund I (closed 1987), KIP China Fund I (closed 2011), KIP PE Fund I (closed 2015), and a Singapore Co-GP Fund (closed 2019). The firm has progressively internationalized its operations, opening China regional headquarters in Shanghai (2008) followed by Beijing (2012), Chengdu (2016), and Guangzhou (2019); a US office in Sunnyvale (2016); and a Southeast Asia office in Singapore (2020). The firm employs 51-100 professionals and generates revenue through fund management fees, carried interest on successful exits, and direct investment returns; specific fee structures and AUM figures are not publicly disclosed.

KIP's distribution advantage stems from its affiliation with Korea Investment Holdings and its group affiliates covering securities, asset management, savings banking, and private equity. The firm was the first Korean venture capital house to receive the Korean Presidential Commendation (2011) and has accumulated multiple industry awards including the Korea IB Best Venture Capital Grand Prize and "Best Venture Capital House" recognition from a top-tier Korean economic magazine. CEO Mahn Soon Hwang, a Seoul National University pharmacy graduate with R&D and biotech investment background, leads the firm alongside CIO Dong Yeob Kim.

Short descriptiontext

Korea Investment Partners is a Seoul-based venture capital and private equity firm and the investment arm of Korea Investment Holdings, investing across biotech, media, fintech, ICT, and semiconductors in Korea, China, the US, and Southeast Asia.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersSeoul, South Korea
HQ citystring
Seoul
HQ countrystring
South Korea
HQ regionstring
Asia
Markets served

Serves global market

Offices7 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
venture capital investment, private equity funds, growth stage equity, biotech healthcare investing, cross-border venture capital
Industry2 codes
1Geography-Focused Venture Capital (Regional/Emerging Markets)
CodeFSANAAAEPrimaryYes
2Multi-Sector / Generalist Growth Equity
CodeFSANACAOPrimaryNo
NAICS code2 codes
  • Portfolio Management and Investment Advice523940
  • Other Financial Investment Activities5239
SIC code1 code
  • Investment Advice6282
Product category
Venture Capital and Private Equity
Social media profiles1 record
Marketing channels2 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Technology or R&D
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Korea Investment Partners is a venture capital and private equity firm that invests pooled fund capital directly into early-stage and growth-stage companies across biotech and healthcare, interactive contents and media, consumer internet and fintech, ICT and digitalization, and semiconductor and industrial sectors. The firm manages multiple dedicated regional funds (KIP Fund I, KIP China Fund I, KIP PE Fund I, Singapore Co-GP Fund) and supports portfolio companies with capital, business operations assistance, and global expansion guidance through its offices in Korea, China, the United States, and Southeast Asia.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Korea Investment Partners is a venture capital and private equity firm that provides investment services across multiple sectors including biotech and healthcare, interactive contents and media, consumer internet and fintech, ICT and digitalization, and semiconductor and industrial. The firm offers fund-oriented professional venture capital investment from early-stage to growth-stage companies, managing various dedicated funds across Korea, China, Southeast Asia, and the United States.

Product and service9 records
1KIP Fund I
CategoryVenture Capital Fund
Description

First dedicated venture capital fund managed by KIP, focused on early-stage venture investments in Korean companies.

2KIP China Fund I
CategoryVenture Capital Fund
Description

First China-focused venture capital fund, supporting investment opportunities in China through KIP's regional office network.

3KIP PE Fund I
CategoryPrivate Equity Fund
Description

Dedicated private equity fund supporting KIP's private equity investment strategies.

4Singapore Co-GP Fund
CategoryCo-Investment Fund
Description

Co-investment vehicle focused on Southeast Asia venture capital and private equity opportunities.

5Biotech & Healthcare Investment Program
CategoryVenture Capital Investment Program
Description

Equity investment program in biotech and healthcare companies, covering image analytics, cell therapy, anticancer, and other new drug developers.

6Interactive Contents & Media Investment Program
CategoryVenture Capital Investment Program
Description

Equity investment program covering interactive contents and media including games, movies, musicals, K-Pop, and concerts.

7Consumer Internet & Fintech Investment Program
CategoryVenture Capital Investment Program
Description

Equity investment program covering consumer internet and fintech sectors including platforms, marketplaces, and payments.

8ICT & Digitalization Investment Program
CategoryVenture Capital Investment Program
Description

Equity investment program covering ICT and digitalization sectors including IoT, telecommunications, AI, autonomous, and mobility companies.

9Semiconductor & Industrial Investment Program
CategoryVenture Capital Investment Program
Description

Equity investment program covering semiconductor and industrial sectors including sensors, semiconductors, OLED, and sophisticated components.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Recent move14 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Asia-focused early-stage VC arm of SoftBank Group. Comparable in geographic scope and technology sector focus, though generally earlier-stage and part of a much larger conglomerate.

TypeBroad incumbent
Description

US-China cross-border VC investing across consumer, enterprise, and frontier tech. Comparable in multi-region platform and diversified sector mandate, particularly relevant to KIP's US and China operations.

TypeDirect peer
Description

Korea-based VC/PE firm operating multiple sector-focused funds. Comparable as a Korea-rooted multi-stage and multi-sector investment manager with similar institutional roots.

TypeBroad incumbent
Description

Asia-focused multi-stage investment manager across PE, VC, and public equities. Comparable in cross-border Asia platform and sector breadth, though operating at significantly larger AUM scale.

TypeRegional player
Description

China-focused VC and growth equity firm under Legend Holdings. Comparable in cross-border China mandate and diversified sector focus, though primarily China-domiciled.

TypeDirect peer
Description

Korean VC arm of the Mirae Asset Financial Group, investing across multiple sectors and stages in Korea and Asia. Highly comparable as a conglomerate-affiliated multi-sector Korean VC.

TypeDirect peer
Description

Korean securities-affiliated VC platform investing across multiple sectors. Comparable as another conglomerate-affiliated Korean VC with multi-sector and growth-stage focus.

TypeDirect peer
Description

Korean VC and growth equity firm with multi-sector investment focus including biotech, ICT, and consumer. Comparable in scale, sector diversification, and Korean/Asian geographic mandate.

TypeBroad incumbent
Description

Multi-stage VC network backed by Temasek operating across SE Asia, China, US, and Israel. Comparable multi-region Asia-anchored platform with diversified sector exposure.

TypeDirect peer
Description

One of Korea's largest alternative investment firms operating across VC, growth equity, and PE with multi-sector and cross-border mandates. Closely comparable to KIP in size, sector breadth, and Korea-China investment focus.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries6 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment8 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Korean Investment Partners

Venture Capital and Private Equitypartners.koreainvestment.com

Korea Investment Partners is a Seoul-based venture capital and private equity firm and the investment arm of Korea Investment Holdings, investing across biotech, media, fintech, ICT, and semiconductors in Korea, China, the US, and Southeast Asia.

What Korean Investment Partners does

Korea Investment Partners (KIP) is a Seoul-headquartered venture capital and private equity firm incorporated in 1986, operating as the dedicated investment arm of Korea Investment Holdings, one of Korea's largest financial conglomerates. The firm invests across five sector verticals — Biotech & Healthcare, Interactive Contents & Media, Consumer Internet & Fintech, ICT & Digitalization, and Semiconductor & Industrial — covering portfolio companies from early-stage ventures through growth-stage businesses.

KIP operates a fund-oriented platform managing at least four distinct vehicles: KIP Fund I (closed 1987), KIP China Fund I (closed 2011), KIP PE Fund I (closed 2015), and a Singapore Co-GP Fund (closed 2019). The firm has progressively internationalized its operations, opening China regional headquarters in Shanghai (2008) followed by Beijing (2012), Chengdu (2016), and Guangzhou (2019); a US office in Sunnyvale (2016); and a Southeast Asia office in Singapore (2020). The firm employs 51-100 professionals and generates revenue through fund management fees, carried interest on successful exits, and direct investment returns; specific fee structures and AUM figures are not publicly disclosed.

KIP's distribution advantage stems from its affiliation with Korea Investment Holdings and its group affiliates covering securities, asset management, savings banking, and private equity. The firm was the first Korean venture capital house to receive the Korean Presidential Commendation (2011) and has accumulated multiple industry awards including the Korea IB Best Venture Capital Grand Prize and "Best Venture Capital House" recognition from a top-tier Korean economic magazine. CEO Mahn Soon Hwang, a Seoul National University pharmacy graduate with R&D and biotech investment background, leads the firm alongside CIO Dong Yeob Kim.

Korean Investment Partners firmographics

Firmographics
Name
Korean Investment Partners
Legal name
Korea Investment Partners Co., Ltd.
Website
https://partners.koreainvestment.com
Company type
Private
Founded year
1986
Operating status
Operating
Headcount range
51–100 employees
Short description
Korea Investment Partners is a Seoul-based venture capital and private equity firm and the investment arm of Korea Investment Holdings, investing across biotech, media, fintech, ICT, and semiconductors in Korea, China, the US, and Southeast Asia.
Ownership category
akta.pro rank

Korean Investment Partners industry classification

Industry
Product category
Venture Capital and Private Equity
NAICS
Portfolio Management and Investment Advice (523940), Other Financial Investment Activities (5239)
SIC
Investment Advice (6282)
akta.pro primary industry
Geography-Focused Venture Capital (Regional/Emerging Markets) (FSANAAAE)
akta.pro secondary industry
Multi-Sector / Generalist Growth Equity (FSANACAO)

Keywords

  • Venture capital investment
  • Private equity funds
  • Growth stage equity
  • Biotech healthcare investing
  • Cross-border venture capital

Where Korean Investment Partners is headquartered

Location

Headquarters

HQ city
Seoul
HQ country
South Korea
HQ region
Asia

Offices7 records

Markets served

Korean Investment Partners business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D

Distribution channels1 record

Marketing channels2 records

Korean Investment Partners product offering

Product offering

Core offering

Korea Investment Partners is a venture capital and private equity firm that invests pooled fund capital directly into early-stage and growth-stage companies across biotech and healthcare, interactive contents and media, consumer internet and fintech, ICT and digitalization, and semiconductor and industrial sectors. The firm manages multiple dedicated regional funds (KIP Fund I, KIP China Fund I, KIP PE Fund I, Singapore Co-GP Fund) and supports portfolio companies with capital, business operations assistance, and global expansion guidance through its offices in Korea, China, the United States, and Southeast Asia.

Product overview

Korea Investment Partners is a venture capital and private equity firm that provides investment services across multiple sectors including biotech and healthcare, interactive contents and media, consumer internet and fintech, ICT and digitalization, and semiconductor and industrial. The firm offers fund-oriented professional venture capital investment from early-stage to growth-stage companies, managing various dedicated funds across Korea, China, Southeast Asia, and the United States.

Differentiator

Problem solved

Functional benefit

Products and services

  • KIP Fund I First dedicated venture capital fund managed by KIP, focused on early-stage venture investments in Korean companies.
  • KIP China Fund I First China-focused venture capital fund, supporting investment opportunities in China through KIP's regional office network.
  • KIP PE Fund I Dedicated private equity fund supporting KIP's private equity investment strategies.
  • Singapore Co-GP Fund Co-investment vehicle focused on Southeast Asia venture capital and private equity opportunities.
  • Biotech & Healthcare Investment Program Equity investment program in biotech and healthcare companies, covering image analytics, cell therapy, anticancer, and other new drug developers.
  • Interactive Contents & Media Investment Program Equity investment program covering interactive contents and media including games, movies, musicals, K-Pop, and concerts.
  • Consumer Internet & Fintech Investment Program Equity investment program covering consumer internet and fintech sectors including platforms, marketplaces, and payments.
  • ICT & Digitalization Investment Program Equity investment program covering ICT and digitalization sectors including IoT, telecommunications, AI, autonomous, and mobility companies.
  • Semiconductor & Industrial Investment Program Equity investment program covering semiconductor and industrial sectors including sensors, semiconductors, OLED, and sophisticated components.

Companies that use Korean Investment Partners

Customer profile

Segments1 record

Ideal customer profiles1 record

Korean Investment Partners technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Korean Investment Partners partnerships and signals

Strategic signal

Scale indicators2 records

Recent moves14 records

Expansion highlights5 records

Korean Investment Partners competitors and assessment

Company assessment

Broad incumbents

  • SoftBank Ventures Asia: Asia-focused early-stage VC arm of SoftBank Group. Comparable in geographic scope and technology sector focus, though generally earlier-stage and part of a much larger conglomerate.
  • GGV Capital: US-China cross-border VC investing across consumer, enterprise, and frontier tech. Comparable in multi-region platform and diversified sector mandate, particularly relevant to KIP's US and China operations.
  • Hillhouse Capital: Asia-focused multi-stage investment manager across PE, VC, and public equities. Comparable in cross-border Asia platform and sector breadth, though operating at significantly larger AUM scale.
  • Vertex Ventures (Temasek): Multi-stage VC network backed by Temasek operating across SE Asia, China, US, and Israel. Comparable multi-region Asia-anchored platform with diversified sector exposure.

Direct peers

  • KB Investment (formerly Korea Growth Investment): Korea-based VC/PE firm operating multiple sector-focused funds. Comparable as a Korea-rooted multi-stage and multi-sector investment manager with similar institutional roots.
  • Mirae Asset Venture Investment: Korean VC arm of the Mirae Asset Financial Group, investing across multiple sectors and stages in Korea and Asia. Highly comparable as a conglomerate-affiliated multi-sector Korean VC.
  • NH Investment & Securities (VC arm): Korean securities-affiliated VC platform investing across multiple sectors. Comparable as another conglomerate-affiliated Korean VC with multi-sector and growth-stage focus.
  • STIC Investments: Korean VC and growth equity firm with multi-sector investment focus including biotech, ICT, and consumer. Comparable in scale, sector diversification, and Korean/Asian geographic mandate.
  • IMM Investment: One of Korea's largest alternative investment firms operating across VC, growth equity, and PE with multi-sector and cross-border mandates. Closely comparable to KIP in size, sector breadth, and Korea-China investment focus.

Regional players

  • Legend Capital: China-focused VC and growth equity firm under Legend Holdings. Comparable in cross-border China mandate and diversified sector focus, though primarily China-domiciled.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Korean Investment Partners social profiles

Digital presence

Korean Investment Partners financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Korean Investment Partners leadership team

Management profile

Number of profiles

Profiles2 records

Korean Investment Partners subsidiaries and ownership

Company hierarchy

Subsidiaries6 records

Korean Investment Partners funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Korean Investment Partners M&A and investment

M&A and investment

M&A

Investments8 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Korean Investment Partners

What does Korean Investment Partners do?

Korea Investment Partners is a venture capital and private equity firm that invests pooled fund capital directly into early-stage and growth-stage companies across biotech and healthcare, interactive contents and media, consumer internet and fintech, ICT and digitalization, and semiconductor and industrial sectors. The firm manages multiple dedicated regional funds (KIP Fund I, KIP China Fund I, KIP PE Fund I, Singapore Co-GP Fund) and supports portfolio companies with capital, business operations assistance, and global expansion guidance through its offices in Korea, China, the United States, and Southeast Asia.

Is Korean Investment Partners a public or private company?

Korean Investment Partners is a private company. It is classified as corporate owned and is currently operating.

When was Korean Investment Partners founded?

Korean Investment Partners was founded in 1986. It employs 51 to 100 people.

Where is Korean Investment Partners based?

Korean Investment Partners is headquartered in Seoul, South Korea, in the Asia region.

Who are Korean Investment Partners's main competitors?

Broad incumbents on record are SoftBank Ventures Asia, GGV Capital, Hillhouse Capital and Vertex Ventures (Temasek). Direct peers are KB Investment (formerly Korea Growth Investment), Mirae Asset Venture Investment, NH Investment & Securities (VC arm), STIC Investments and IMM Investment. Legend Capital is listed as a regional player.

Does Korean Investment Partners have an API?

No public API is recorded for Korean Investment Partners.

What industry is Korean Investment Partners in?

Korean Investment Partners's product category is Venture Capital and Private Equity. Its primary akta.pro industry code is FSANAAAE, Geography-Focused Venture Capital (Regional/Emerging Markets), with a secondary code of FSANACAO, Multi-Sector / Generalist Growth Equity. Its NAICS code is 523940 and its SIC code is 6282.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR Newswire APACMalaysia's LiveIn Achieves Pre-Series B Funding Milestone, Surpasses $10.95M with Key Investment from Korean Investment Partners (KIP) to Propel Growth in Southeast AsiaMalaysian long-stay provider LiveIn secured an additional $2.6 million USD from Korean Investment Partners (KIP), bringing its total pre-Series B funding to over $10.95 million USD. The investment, which also includes backing from InterVest and Wavemaker Partners, will fuel LiveIn's regional expansion into Indonesia following successful operations in Malaysia, Thailand, and Vietnam. This capital injection supports the company's strategy of transforming vacant properties into affordable housing for young adults across Southeast Asia.Malaysia Latest NewsMalaysia’s LiveIn Achieves Pre-Series B Funding Milestone, Surpasses $10.95M with Key Investment from Korean Investment Partners (KIP) to Propel Growth in Southeast AsiaLiveIn, Malaysia’s leading long-stay provider, has received a $2.6 million investment from Korean Investment Partners (KIP) as part of its pre-Series B funding round, surpassing a total of $10.95 million. The funds will support LiveIn's expansion in Southeast Asia, focusing on transforming vacant properties into affordable housing for young adults. LiveIn aims to increase its presence in Vietnam and launch operations in Indonesia by 2024 due to the high demand for affordable housing.Silicon Valley JournalsRgenta Therapeutics Raises $52M in Series A Funding RoundRgenta Therapeutics completed a $52 million Series A funding round led by AZ-CICC Healthcare Investment Fund, with participation from investors including Korean Investment Partners and Delos Capital. The company utilizes a proprietary platform to develop oral, small-molecule RNA-targeting medicines for oncology and neurological disorders. This capital will be used to accelerate lead project development and expand the company's therapeutic pipeline.